查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024929

性行為感染傳染病（STD）診斷市場規模、佔有率、趨勢和預測：按類型、設備類型、最終用戶和地區分類，2026-2034 年

Sexually Transmitted Disease (STD) Diagnostics Market Size, Share, Trends and Forecast by Type, Device Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球性行為感染（STI）診斷市場規模為1,139億美元。展望未來，IMARC Group預測，該市場將以4.29%的複合年成長率從2026年成長至2034年，到2034年達到1,682億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過36.8%。性行為感染診斷市場佔有率的擴大主要歸因於性行為感染盛行率的上升、大眾對早期診斷意識的增強以及家用性傳染感染檢測套組的推出。

性行為感染傳染病 (STD) 診斷是指為識別和確認是否存在性行為感染感染 (STI) 而進行的各項檢測、檢查和拭子培養。這包括血液檢測、體液檢測和尿液檢查，以檢測特定性行為感染的抗體或性行為感染。這些檢測廣泛用於檢測和篩檢各種性行為感染和感染疾病，包括生殖器疥瘡、披衣菌感染、淋病、梅毒、陰蝨、滴蟲病、後天免疫力缺乏缺乏症候群 (AIDS)、細菌性陰道炎、疥瘡和軟性下疳。 STD 診斷有助於早期發現和準確治療，預防不孕，保護胎兒免受感染，並最大限度地減少疾病傳播。這些診斷方法還有助於降低潛在的長期風險，增強患者的信心，並為醫生提供有關疾病及其病因的寶貴資訊。

性行為感染（STI）診斷市場趨勢：

由於無保護性行為和藥物濫用導致性行為感染（STI）的日益流行，是推動市場成長的主要因素。性傳染病（STD）診斷廣泛用於檢測各種引起STD的病原體，包括細菌、病毒和寄生蟲。其高精度和高可靠性有助於醫療專業人員確定合適的治療方法，預防母嬰傳播，並改善患者的臨床療效。此外，大眾對早期發現和診斷STD重要性的認知不斷提高，這可以預防不孕症、出生缺陷、癌症、失明、骨骼畸形、腦損傷和智慧障礙等長期併發症，也是推動市場成長的另一個因素。此外，政府主導的各項旨在提高公眾對性健康和性行為感染檢測的認知，並透過教育宣傳活動、研討會和社群媒體廣告消除相關社會污名的舉措，也在促進市場成長。同時，經濟高效、安全、準確、便利、快速出結果且保護隱私的家用性行為感染檢測套組的推出，也對市場成長產生了正面影響。此外，近年來，基於人工智慧（AI）的行動應用程式的開發，能夠分析個人生殖器的數位影像以診斷性行為感染（STI），這提高了性傳染性行為感染篩檢的可及性，同時確保了隱私並保護了個人數據，這也推動了市場成長。其他預計推動市場成長的因素包括醫療產業的顯著成長、透過電子商務平台輕鬆取得性傳染病診斷試劑盒，以及對新型診斷技術研發投入的增加。

本報告解答的主要問題：

  • 全球性行為感染感染（STI）診斷市場目前的發展狀況如何？未來幾年我們預計會看到哪些趨勢？
  • 全球性行為感染（STI）診斷市場的市場促進因素、限制因素和機會是什麼？
  • 各種促進因素​​、阻礙因素和機會如何影響全球性行為感染（STI）診斷市場？
  • 主要區域市場有哪些？
  • 哪個國家對性行為感染（STI）診斷產品的需求市場最大？
  • 按類型分類的市場組成是什麼？
  • 在性行為感染感染（STI）診斷市場中，哪種類型最吸引人？
  • 按設備類型分類的市場區隔如何？
  • 在性行為感染感染（STI）診斷市場中，哪種類型的設備最具吸引力？
  • 依最終用戶分類的市場區隔如何？
  • 在性行為感染感染（STI）診斷市場中，哪個終端用戶最具吸引力？
  • 全球性行為感染感染（STI）診斷市場的競爭格局如何？
  • 全球性行為感染（STI）診斷市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球性行為感染傳染病（STD）診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 披衣菌感染檢測
  • 梅毒檢測
  • 淋病檢測
  • 單純皰疹病毒檢測
  • 人類乳突病毒 (HPV) 檢測
  • 人類免疫力缺乏）檢測
  • 軟性下疳檢查
  • 其他

第7章 市場區隔：依設備類型分類

  • 實驗室設備
    • 主要部分
      • 聚合酵素連鎖反應熱迴圈儀（PCR）
      • 側向流讀取儀
      • 流式細胞儀
      • 吸光度微孔盤讀數儀 -酵素免疫分析法(ELISA)
      • 其他
  • 即時偵測（PoC）設備
    • 主要部分
      • 智慧型手機晶片（微流體技術+資訊通訊技術）
      • 可攜式/桌上型/快速診斷套件

第8章 市場區隔：依最終用戶分類

  • 實驗室檢測
  • 即時檢測

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Cepheid（Danaher Corporation）
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • Qiagen NV
    • Quidel Corporation
    • Siemens Healthineers AG（Siemens AG）
Product Code: SR112026A6956

The global sexually transmitted disease (STD) diagnostics market size was valued at USD 113.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 168.2 Billion by 2034, exhibiting a CAGR of 4.29% from 2026-2034. North America currently dominates the market, holding a market share of over 36.8% in 2025. The sexually transmitted disease (STD) diagnostics market share is increasing due to rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual's private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

This report provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market report, along with forecasts at the global, regional and country levels from 2026-2034. The report has categorized the market based on type, device type, and end user.

Type Insights:

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Others

Device Type Insights:

  • Laboratory Devices
  • Thermal Cycler - PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
  • Point of Care (PoC) Devices
  • Phone Chips (Microfluidics + ICT)
  • Portable/Bench Top/Rapid Diagnostic Kits

End User Insights:

  • Laboratory Testing
  • Point of Care (PoC) Testing

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
  • What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
  • Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sexually Transmitted Disease (STD) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Chlamydia Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Syphilis Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gonorrhea Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Herpes Simplex Virus Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Human Papilloma Virus Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Human Immunodeficiency Virus Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chancroid Testing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Laboratory Devices
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Thermal Cyclers - PCR
      • 7.1.2.2 Lateral Flow Readers
      • 7.1.2.3 Flow Cytometers
      • 7.1.2.4 Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Point of Care (PoC) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Phone Chips (Microfluidics + ICT)
      • 7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Laboratory Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Point of Care Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hologic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Qiagen N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Quidel Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2025
  • Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
  • Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sexually Transmitted Disease Diagnostics Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Device Type (in Million USD), 2026-2034
  • Table 4: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Sexually Transmitted Disease Diagnostics Market: Competitive Structure
  • Table 7: Global: Sexually Transmitted Disease Diagnostics Market: Key Players